Extended-spectrum β-lactamases: Epidemiology, detection, and treatment

S. Nathisuwan, D. S. Burgess, J. S. Lewis

Producción científica: Review articlerevisión exhaustiva

153 Citas (Scopus)

Resumen

Extended-spectrum β-lactamases (ESBLs) are extremely broad spectrum β-lactamase enzymes found in a variety of Enterobacteriaceae. Most strains producing these β-lactamases are Klebsiella pneumoniae, other Klebsiella species (i.e., K. oxytoca), and Escherichia coli. When producing these enzymes, organisms become highly effective at inactivating various β-lactam antibiotics. In addition, ESBL-producing bacteria are frequently resistant to many classes of antibiotics, resulting in difficult-to-treat infections. Other problems due to ESBL-producing bacteria are difficulty in detecting the presence of ESBLs, limited treatment options, and deleterious impact on clinical outcomes. Clinicians should be familiar with the clinical significance of these enzymes and potential strategies for dealing with this growing problem.

Idioma originalEnglish
Páginas (desde-hasta)920-928
Número de páginas9
PublicaciónPharmacotherapy
Volumen21
N.º8
DOI
EstadoPublished - 2001

ASJC Scopus subject areas

  • Pharmacology (medical)

Huella

Profundice en los temas de investigación de 'Extended-spectrum β-lactamases: Epidemiology, detection, and treatment'. En conjunto forman una huella única.

Citar esto